CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT
- Institution
- CTIS, INC., MD
- Principal investigator
- Sudhir Raju
- Funding
- $18.0M
- Duration
- 2022–2026
Moonbase score
Still being scored
Abstract
The objective of the Cancer Therapy Evaluation Program Informatics & Computer Support contract is to assist in achievement of the scientific goals of CTEP and the NCI while delivering operational efficiency to new and future business practices by designing, developing, implementing, and integrating innovative data collection systems, management tools, information storage, and communication systems. These tools, methods, and systems are termed the CTEP Enterprise System (CTEP-ESYS) and assist in the review, management, and conduct of oncology clinical trials and investigational agent development. The CTEP-ESYS contract is responsible for 1) providing a cost-effective approach to address administrative, scientific, and regulatory concerns; 2) providing reliable clinical results and toxicity data; enabling a shift in focus from administrative tasks to science for the scientists and physicians; 3) improving patient/trial safety; 4) ensuring the security and confidentiality of proprietary and patient information; 5) eliminating data redundancy throughout the oncology community; and 6) empowering personnel to make educated decisions by improving access to quality and timely data.
LOADING MOONBASE SCORE
Questions for Ctis, Inc.
Ctis, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same topic, scored first.
- NSF · Softhread, Inc.71
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
Anthony P Deasey · $985K · 2024–2026
- NIH · University of CincinnatiNot yet scored
Training Program in Basic and Translational Oncology
Vinita Takiar · $383K · 2025–2030
- NIH · UT Southwestern Medical CenterNot yet scored
A Novel Benefits Navigator Intervention to Address Unmet Social Needs in Pediatric Oncology
Puja Jagdish Umaretiya · $250K · 2025–2030